Surrogate markers for vascular micro- and macrovascular hard endpoints for innovative diabetes tools

  • Description
  • Details
  • Subprojects
  • History
  • Relations
  • Publications
Project Title: Surrogate markers for vascular micro- and macrovascular hard endpoints for innovative diabetes tools
Project Number: CORDIS-203678
Project web address: Follow on CORDIS
Organization: Boehriger Ingelheim International Gmbh, Germany, Ingelheim
Collaborators: Lund University, SE
University Of Edinburgh, GB
Goeteborgs Universitet, SE
University Of Dundee, GB
Karolinska Institutet, SE
University Of Exeter, GB
Università Cattolica Del Sacro Cuore, IT
Universita Degli Studi Di Padova, IT
The Chancellor, Masters And Scholars Of The University Of Oxford, GB
The Chancellor, Masters And Scholars Of The University Of Cambridge, GB
Università Degli Studi Di Firenze, IT
Universitá Degli Studi Di Pavia, IT
Universita Di Pisa, IT
Istituto Di Ricerche Farmacologiche Mario Negri, IT
F. Hoffmann - La Roche Ltd., CH
Pfizer Ltd, GB
Eli Lilly Company Limited, GB
Astra Zeneca Ab, SE
Turun Yliopisto, FI
Sanofi-Aventis Deutschland Gmbh, DE
Helmholtz Zentrum Muenchen- Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh, DE
Itä-Suomen Yliopisto, FI
Samfundet Folkhälsan I Svenska Finland R.F., FI
Terveyden Ja Hyvinvoinnin Laitos, FI
Biocomputing Platforms Ltd Oy, FI
Principal Investigators (PI): Diane Taylor, GB
Angela Noble, GB
Juergen Ertel, DE
Keith Cann, GB
Maria Grazia Pezzoni, IT
Antonio Camporese, IT
Edward Gibbs, GB
Caroline Hamilton, SE
Filippo Leone, IT
Christer Holmstrom, FI
Catherine Serjeant, GB
Bernd Jablonka, DE
Tinna Carlsson, SE
Eva Lindgren, SE
Anita Eliasson, FI
Perini Elena, IT
Eliisa Särkilahti, FI
Janne Luomala, FI
Birgit Steckel-Hamann, GB
Sofia Baggini, IT
Cristina Dolfi, IT
Jason Hannon, CH
Jacqueline Postma, SE
Olga Krylova, GB
Seppo Ylä-Herttuala, FI
Michael Mark, DE
 
Project Description:
Diabetes mellitus is a lifelong, incapacitating disease affecting multiple organs. Worldwide prevalence figures estimate that there will be 246 million diabetic patients in 2007 and 380 million in 2025. Presently, diabetes can neither be prevented nor cured and the disease is associated with devastating chronic complications including coronary heart disease and stroke (macrovascular disease) as well as microvascular disorders leading to damage of the small blood vessels of the kidney (nephropathy), eye(retinopathy) and peripheral nerves (neuropathy). These complications impose an immense burden on the quality of life of the patients and account for more than 10% of health care costs in Europe. Therefore, novel means to prevent these devastating diabetic complications are needed. An important mean in this undertaking would be to develop tools which would make development of novel drugs for prevention of complications more feasible. The SUMMIT consortium brings together European key leaders in the field of diabetes research; scientists with a deep insight into genetics, biomarker discovery, development of novel imaging assays for assessing progression of complications, novel animal models for chronic diabetic complications, in silico models to predict development of complications and response to novel treatments. Given the track record of this unique group of scientists, it can be anticipated that they will not only during the 6-year period discover novel surrogate markers for vascular complications in diabetes, but also validate them in large representative cohorts aiming at prevention of the devastating complications.
 
Project Terms:
There are no related terms in database.
Project Title: Surrogate markers for vascular micro- and macrovascular hard endpoints for innovative diabetes tools
Project Number: CORDIS-203678
Project web address: Follow on CORDIS
Organization: Boehriger Ingelheim International Gmbh, Germany, Ingelheim
Collaborators: Lund University, SE
University Of Edinburgh, GB
Goeteborgs Universitet, SE
University Of Dundee, GB
Karolinska Institutet, SE
University Of Exeter, GB
Università Cattolica Del Sacro Cuore, IT
Universita Degli Studi Di Padova, IT
The Chancellor, Masters And Scholars Of The University Of Oxford, GB
The Chancellor, Masters And Scholars Of The University Of Cambridge, GB
Università Degli Studi Di Firenze, IT
Universitá Degli Studi Di Pavia, IT
Universita Di Pisa, IT
Istituto Di Ricerche Farmacologiche Mario Negri, IT
F. Hoffmann - La Roche Ltd., CH
Pfizer Ltd, GB
Eli Lilly Company Limited, GB
Astra Zeneca Ab, SE
Turun Yliopisto, FI
Sanofi-Aventis Deutschland Gmbh, DE
Helmholtz Zentrum Muenchen- Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh, DE
Itä-Suomen Yliopisto, FI
Samfundet Folkhälsan I Svenska Finland R.F., FI
Terveyden Ja Hyvinvoinnin Laitos, FI
Biocomputing Platforms Ltd Oy, FI
Principal Investigators (PI): Diane Taylor, GB
Angela Noble, GB
Juergen Ertel, DE
Keith Cann, GB
Maria Grazia Pezzoni, IT
Antonio Camporese, IT
Edward Gibbs, GB
Caroline Hamilton, SE
Filippo Leone, IT
Christer Holmstrom, FI
Catherine Serjeant, GB
Bernd Jablonka, DE
Tinna Carlsson, SE
Eva Lindgren, SE
Anita Eliasson, FI
Perini Elena, IT
Eliisa Särkilahti, FI
Janne Luomala, FI
Birgit Steckel-Hamann, GB
Sofia Baggini, IT
Cristina Dolfi, IT
Jason Hannon, CH
Jacqueline Postma, SE
Olga Krylova, GB
Seppo Ylä-Herttuala, FI
Michael Mark, DE
 
Project Categories:
Natural Sciences > Aging Diseases and Pathology > Cardiovascular and cerebrovascular diseases
 
Other Information:
Fiscal Year: 2009
Project Start Date: 1 November 2009
Project End Date: 31 October 2015
Project program: FP7-JTI
 
Project Funding Information:
Funding Mechanism: JTI-CP-IMI - Joint Technology Initiatives - Collaborative Project (IMI)
Year Funding Organization Total Funding, $
2009 European Research Council $36,982,216
Project Title: Surrogate markers for vascular micro- and macrovascular hard endpoints for innovative diabetes tools
Project Number: CORDIS-203678
Project web address: Follow on CORDIS
Organization: Boehriger Ingelheim International Gmbh, Germany, Ingelheim
Collaborators: Lund University, SE
University Of Edinburgh, GB
Goeteborgs Universitet, SE
University Of Dundee, GB
Karolinska Institutet, SE
University Of Exeter, GB
Università Cattolica Del Sacro Cuore, IT
Universita Degli Studi Di Padova, IT
The Chancellor, Masters And Scholars Of The University Of Oxford, GB
The Chancellor, Masters And Scholars Of The University Of Cambridge, GB
Università Degli Studi Di Firenze, IT
Universitá Degli Studi Di Pavia, IT
Universita Di Pisa, IT
Istituto Di Ricerche Farmacologiche Mario Negri, IT
F. Hoffmann - La Roche Ltd., CH
Pfizer Ltd, GB
Eli Lilly Company Limited, GB
Astra Zeneca Ab, SE
Turun Yliopisto, FI
Sanofi-Aventis Deutschland Gmbh, DE
Helmholtz Zentrum Muenchen- Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh, DE
Itä-Suomen Yliopisto, FI
Samfundet Folkhälsan I Svenska Finland R.F., FI
Terveyden Ja Hyvinvoinnin Laitos, FI
Biocomputing Platforms Ltd Oy, FI
Principal Investigators (PI): Diane Taylor, GB
Angela Noble, GB
Juergen Ertel, DE
Keith Cann, GB
Maria Grazia Pezzoni, IT
Antonio Camporese, IT
Edward Gibbs, GB
Caroline Hamilton, SE
Filippo Leone, IT
Christer Holmstrom, FI
Catherine Serjeant, GB
Bernd Jablonka, DE
Tinna Carlsson, SE
Eva Lindgren, SE
Anita Eliasson, FI
Perini Elena, IT
Eliisa Särkilahti, FI
Janne Luomala, FI
Birgit Steckel-Hamann, GB
Sofia Baggini, IT
Cristina Dolfi, IT
Jason Hannon, CH
Jacqueline Postma, SE
Olga Krylova, GB
Seppo Ylä-Herttuala, FI
Michael Mark, DE
 
Title FY Funding
There are no results for this project in database.
Project Title: Surrogate markers for vascular micro- and macrovascular hard endpoints for innovative diabetes tools
Project Number: CORDIS-203678
Project web address: Follow on CORDIS
Organization: Boehriger Ingelheim International Gmbh, Germany, Ingelheim
Collaborators: Lund University, SE
University Of Edinburgh, GB
Goeteborgs Universitet, SE
University Of Dundee, GB
Karolinska Institutet, SE
University Of Exeter, GB
Università Cattolica Del Sacro Cuore, IT
Universita Degli Studi Di Padova, IT
The Chancellor, Masters And Scholars Of The University Of Oxford, GB
The Chancellor, Masters And Scholars Of The University Of Cambridge, GB
Università Degli Studi Di Firenze, IT
Universitá Degli Studi Di Pavia, IT
Universita Di Pisa, IT
Istituto Di Ricerche Farmacologiche Mario Negri, IT
F. Hoffmann - La Roche Ltd., CH
Pfizer Ltd, GB
Eli Lilly Company Limited, GB
Astra Zeneca Ab, SE
Turun Yliopisto, FI
Sanofi-Aventis Deutschland Gmbh, DE
Helmholtz Zentrum Muenchen- Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh, DE
Itä-Suomen Yliopisto, FI
Samfundet Folkhälsan I Svenska Finland R.F., FI
Terveyden Ja Hyvinvoinnin Laitos, FI
Biocomputing Platforms Ltd Oy, FI
Principal Investigators (PI): Diane Taylor, GB
Angela Noble, GB
Juergen Ertel, DE
Keith Cann, GB
Maria Grazia Pezzoni, IT
Antonio Camporese, IT
Edward Gibbs, GB
Caroline Hamilton, SE
Filippo Leone, IT
Christer Holmstrom, FI
Catherine Serjeant, GB
Bernd Jablonka, DE
Tinna Carlsson, SE
Eva Lindgren, SE
Anita Eliasson, FI
Perini Elena, IT
Eliisa Särkilahti, FI
Janne Luomala, FI
Birgit Steckel-Hamann, GB
Sofia Baggini, IT
Cristina Dolfi, IT
Jason Hannon, CH
Jacqueline Postma, SE
Olga Krylova, GB
Seppo Ylä-Herttuala, FI
Michael Mark, DE
 
Project Title Organization FY Funding
Surrogate Markers For Vascular Micro- And Macrovascular Hard Endpoints For Innovative Diabetes ToolsBoehriger Ingelheim International Gmbh2009$36,982,216
Project Title: Surrogate markers for vascular micro- and macrovascular hard endpoints for innovative diabetes tools
Project Number: CORDIS-203678
Project web address: Follow on CORDIS
Organization: Boehriger Ingelheim International Gmbh, Germany, Ingelheim
Collaborators: Lund University, SE
University Of Edinburgh, GB
Goeteborgs Universitet, SE
University Of Dundee, GB
Karolinska Institutet, SE
University Of Exeter, GB
Università Cattolica Del Sacro Cuore, IT
Universita Degli Studi Di Padova, IT
The Chancellor, Masters And Scholars Of The University Of Oxford, GB
The Chancellor, Masters And Scholars Of The University Of Cambridge, GB
Università Degli Studi Di Firenze, IT
Universitá Degli Studi Di Pavia, IT
Universita Di Pisa, IT
Istituto Di Ricerche Farmacologiche Mario Negri, IT
F. Hoffmann - La Roche Ltd., CH
Pfizer Ltd, GB
Eli Lilly Company Limited, GB
Astra Zeneca Ab, SE
Turun Yliopisto, FI
Sanofi-Aventis Deutschland Gmbh, DE
Helmholtz Zentrum Muenchen- Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh, DE
Itä-Suomen Yliopisto, FI
Samfundet Folkhälsan I Svenska Finland R.F., FI
Terveyden Ja Hyvinvoinnin Laitos, FI
Biocomputing Platforms Ltd Oy, FI
Principal Investigators (PI): Diane Taylor, GB
Angela Noble, GB
Juergen Ertel, DE
Keith Cann, GB
Maria Grazia Pezzoni, IT
Antonio Camporese, IT
Edward Gibbs, GB
Caroline Hamilton, SE
Filippo Leone, IT
Christer Holmstrom, FI
Catherine Serjeant, GB
Bernd Jablonka, DE
Tinna Carlsson, SE
Eva Lindgren, SE
Anita Eliasson, FI
Perini Elena, IT
Eliisa Särkilahti, FI
Janne Luomala, FI
Birgit Steckel-Hamann, GB
Sofia Baggini, IT
Cristina Dolfi, IT
Jason Hannon, CH
Jacqueline Postma, SE
Olga Krylova, GB
Seppo Ylä-Herttuala, FI
Michael Mark, DE
 
Project number Project title Principal investigator
There are no any related projects.
Project Title: Surrogate markers for vascular micro- and macrovascular hard endpoints for innovative diabetes tools
Project Number: CORDIS-203678
Project web address: Follow on CORDIS
Organization: Boehriger Ingelheim International Gmbh, Germany, Ingelheim
Collaborators: Lund University, SE
University Of Edinburgh, GB
Goeteborgs Universitet, SE
University Of Dundee, GB
Karolinska Institutet, SE
University Of Exeter, GB
Università Cattolica Del Sacro Cuore, IT
Universita Degli Studi Di Padova, IT
The Chancellor, Masters And Scholars Of The University Of Oxford, GB
The Chancellor, Masters And Scholars Of The University Of Cambridge, GB
Università Degli Studi Di Firenze, IT
Universitá Degli Studi Di Pavia, IT
Universita Di Pisa, IT
Istituto Di Ricerche Farmacologiche Mario Negri, IT
F. Hoffmann - La Roche Ltd., CH
Pfizer Ltd, GB
Eli Lilly Company Limited, GB
Astra Zeneca Ab, SE
Turun Yliopisto, FI
Sanofi-Aventis Deutschland Gmbh, DE
Helmholtz Zentrum Muenchen- Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh, DE
Itä-Suomen Yliopisto, FI
Samfundet Folkhälsan I Svenska Finland R.F., FI
Terveyden Ja Hyvinvoinnin Laitos, FI
Biocomputing Platforms Ltd Oy, FI
Principal Investigators (PI): Diane Taylor, GB
Angela Noble, GB
Juergen Ertel, DE
Keith Cann, GB
Maria Grazia Pezzoni, IT
Antonio Camporese, IT
Edward Gibbs, GB
Caroline Hamilton, SE
Filippo Leone, IT
Christer Holmstrom, FI
Catherine Serjeant, GB
Bernd Jablonka, DE
Tinna Carlsson, SE
Eva Lindgren, SE
Anita Eliasson, FI
Perini Elena, IT
Eliisa Särkilahti, FI
Janne Luomala, FI
Birgit Steckel-Hamann, GB
Sofia Baggini, IT
Cristina Dolfi, IT
Jason Hannon, CH
Jacqueline Postma, SE
Olga Krylova, GB
Seppo Ylä-Herttuala, FI
Michael Mark, DE
 
Title Journal Year Country Rel